ミシガン州におけるパーキンソン病の臨床試験
ミシガン州内の拠点で、パーキンソン病に関する21件の研究が参加者を募集しています。
ミシガン州内の都市
公式研究テキスト（英語）
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Quest Research Institute, Farmington Hills
被験者募集中第2相
40歳〜80歳 · 全性別 · 2026/10/02更新 · NCT06680830A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
- Quest Research Institute - Alcanza, Farmington Hills
被験者募集中第1相健康なボランティア歓迎
30歳〜80歳 · 全性別 · 2026/10/01更新 · NCT06565195A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-015, Farmington Hills
被験者募集中第2/3相
40歳〜80歳 · 全性別 · 2026/09/28更新 · NCT06976268A Study of Buntanetap in Participants With PD
- Quest Research Institute, Farmington Hills
被験者募集中第2/3相
40歳〜85歳 · 全性別 · 2026/09/21更新 · NCT07284784Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- University of Michigan, Ann Arbor
- Michigan State University, East Lansing
- Quest Research Institute, Farmington Hills
被験者募集中第2相
40歳〜80歳 · 全性別 · 2026/09/21更新 · NCT07005180A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #002, Farmington Hills
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/11更新 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- University of Michigan Health System (UMHS) (Site #202), Ann Arbor
- Quest Research Institute - Alcanza - PPDS (Site #201), Farmington Hills
被験者募集中第2相
30歳〜80歳 · 全性別 · 2026/09/10更新 · NCT07432958A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
- Quest Research Institute - Alcanza - HyperCore - PPDS, Farmington Hills
被験者募集中第2相
40歳〜85歳 · 全性別 · 2026/09/08更新 · NCT07514858A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- University of Michigan, Ann Arbor
被験者募集中観察研究
45歳〜75歳 · 全性別 · 2026/09/04更新 · NCT07330258A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Quest Research Institute, Farmington Hills
被験者募集中第3相
50歳〜85歳 · 全性別 · 2026/09/03更新 · NCT07174310A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease
- Domino's Farms, Ann Arbor
被験者募集中第1相
50歳以上 · 全性別 · 2026/08/14更新 · NCT07543861A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Michigan Clinical Research Unit - Neurology, Ann Arbor
- University of Michigan Clinical Research Unit - Neurology, Ann Arbor
- Quest Research Institute, Farmington Hills
被験者募集中第3相
45歳〜75歳 · 全性別 · 2026/08/04更新 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- University of Michigan, Ann Arbor
被験者募集中観察研究健康なボランティア歓迎
30歳以上 · 全性別 · 2026/07/27更新 · NCT04477785Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation
- University of Michigan, Ann Arbor
被験者募集中観察研究
45歳以上 · 全性別 · 2026/06/11更新 · NCT07642908Natural History Study of Synucleinopathies
- University of Michigan, Ann Arbor
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/10更新 · NCT01799915SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
- Quest Research Institute, Farmington Hills
被験者募集中第1相
40歳〜80歳 · 全性別 · 2026/06/05更新 · NCT07422675Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements
- Michigan State University, East Lansing
被験者募集中
50歳以上 · 全性別 · 2026/05/20更新 · NCT07599696A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- QUEST Research Institute, Farmington Hills
被験者募集中第1相健康なボランティア歓迎
30歳〜85歳 · 全性別 · 2026/04/20更新 · NCT06809400Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease
- University of Michigan, Ann Arbor
被験者募集中第2相
45歳以上 · 全性別 · 2026/03/31更新 · NCT06679374Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
- Domino's Farms, Ann Arbor
被験者募集中第1/2相
45歳以上 · 全性別 · 2025/11/12更新 · NCT07154511A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Quest Research Institute, Farmington Hills
被験者募集中第4相
18歳以上 · 全性別 · 2025/08/24更新 · NCT06765668ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。